Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke
Clinical trial NCT03993236 · COMPLETED
Trial details
- NCT number
- NCT03993236
- Sponsor
- Keun-Sik Hong
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-09
- Primary completion
- 2021-09-27
- Enrollment
- 584
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.